GH RESEARCH PLC (GHRS) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:GHRS • IE000GID8VI0

15.165 USD
+1.5 (+11.02%)
At close: Feb 6, 2026
15.165 USD
0 (0%)
After Hours: 2/6/2026, 8:00:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to GHRS. GHRS was compared to 191 industry peers in the Pharmaceuticals industry. The financial health of GHRS is average, but there are quite some concerns on its profitability. GHRS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year GHRS has reported negative net income.
  • GHRS had a negative operating cash flow in the past year.
  • In the past 5 years GHRS always reported negative net income.
  • In the past 5 years GHRS always reported negative operating cash flow.
GHRS Yearly Net Income VS EBIT VS OCF VS FCFGHRS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

  • With a decent Return On Assets value of -14.21%, GHRS is doing good in the industry, outperforming 63.35% of the companies in the same industry.
  • With a decent Return On Equity value of -14.73%, GHRS is doing good in the industry, outperforming 70.16% of the companies in the same industry.
Industry RankSector Rank
ROA -14.21%
ROE -14.73%
ROIC N/A
ROA(3y)-15.08%
ROA(5y)-11.23%
ROE(3y)-15.67%
ROE(5y)-11.65%
ROIC(3y)N/A
ROIC(5y)N/A
GHRS Yearly ROA, ROE, ROICGHRS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -20 -40 -60

1.3 Margins

  • GHRS does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GHRS Yearly Profit, Operating, Gross MarginsGHRS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • GHRS has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for GHRS has been increased compared to 5 years ago.
  • Compared to 1 year ago, GHRS has an improved debt to assets ratio.
GHRS Yearly Shares OutstandingGHRS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
GHRS Yearly Total Debt VS Total AssetsGHRS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

  • An Altman-Z score of 53.03 indicates that GHRS is not in any danger for bankruptcy at the moment.
  • GHRS's Altman-Z score of 53.03 is amongst the best of the industry. GHRS outperforms 96.34% of its industry peers.
  • A Debt/Equity ratio of 0.00 indicates that GHRS is not too dependend on debt financing.
  • The Debt to Equity ratio of GHRS (0.00) is better than 62.30% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 53.03
ROIC/WACCN/A
WACCN/A
GHRS Yearly LT Debt VS Equity VS FCFGHRS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

  • A Current Ratio of 28.32 indicates that GHRS has no problem at all paying its short term obligations.
  • GHRS's Current ratio of 28.32 is amongst the best of the industry. GHRS outperforms 95.29% of its industry peers.
  • A Quick Ratio of 28.32 indicates that GHRS has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 28.32, GHRS belongs to the best of the industry, outperforming 95.29% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 28.32
Quick Ratio 28.32
GHRS Yearly Current Assets VS Current LiabilitesGHRS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 6.33% over the past year.
EPS 1Y (TTM)6.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to decrease by -17.69% on average over the next years. This is quite bad
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-12.22%
EPS Next 2Y-49.86%
EPS Next 3Y-34.92%
EPS Next 5Y-17.69%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GHRS Yearly Revenue VS EstimatesGHRS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 2029 2030 2031 2032 2033 500M 1B 1.5B
GHRS Yearly EPS VS EstimatesGHRS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 4 6 8

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • GHRS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GHRS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GHRS Price Earnings VS Forward Price EarningsGHRS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GHRS Per share dataGHRS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

  • A cheap valuation may be justified as GHRS's earnings are expected to decrease with -34.92% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-49.86%
EPS Next 3Y-34.92%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for GHRS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

GH RESEARCH PLC

NASDAQ:GHRS (2/6/2026, 8:00:01 PM)

After market: 15.165 0 (0%)

15.165

+1.5 (+11.02%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-06
Earnings (Next)02-26
Inst Owners71.84%
Inst Owner Change-0.26%
Ins Owners26.78%
Ins Owner ChangeN/A
Market Cap940.68M
Revenue(TTM)N/A
Net Income(TTM)-42.92M
Analysts84
Price Target34.42 (126.97%)
Short Float %5.6%
Short Ratio6.04
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.96%
Min EPS beat(2)4.72%
Max EPS beat(2)31.2%
EPS beat(4)4
Avg EPS beat(4)29.92%
Min EPS beat(4)4.72%
Max EPS beat(4)52.24%
EPS beat(8)7
Avg EPS beat(8)22.1%
EPS beat(12)10
Avg EPS beat(12)15.3%
EPS beat(16)14
Avg EPS beat(16)29.24%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)11.11%
PT rev (3m)8.43%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.41%
EPS NY rev (1m)0.15%
EPS NY rev (3m)2.21%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.23
P/tB 3.23
EV/EBITDA N/A
EPS(TTM)-0.74
EYN/A
EPS(NY)-1.68
Fwd EYN/A
FCF(TTM)-0.67
FCFYN/A
OCF(TTM)-0.67
OCFYN/A
SpS0
BVpS4.7
TBVpS4.7
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -14.21%
ROE -14.73%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-15.08%
ROA(5y)-11.23%
ROE(3y)-15.67%
ROE(5y)-11.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 39.08%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 28.32
Quick Ratio 28.32
Altman-Z 53.03
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)62.43%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y-12.22%
EPS Next 2Y-49.86%
EPS Next 3Y-34.92%
EPS Next 5Y-17.69%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-22.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-15.96%
EBIT Next 3Y-24.63%
EBIT Next 5Y-14.58%
FCF growth 1Y-29.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-29.73%
OCF growth 3YN/A
OCF growth 5YN/A

GH RESEARCH PLC / GHRS FAQ

What is the ChartMill fundamental rating of GH RESEARCH PLC (GHRS) stock?

ChartMill assigns a fundamental rating of 2 / 10 to GHRS.


Can you provide the valuation status for GH RESEARCH PLC?

ChartMill assigns a valuation rating of 0 / 10 to GH RESEARCH PLC (GHRS). This can be considered as Overvalued.


How profitable is GH RESEARCH PLC (GHRS) stock?

GH RESEARCH PLC (GHRS) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for GHRS stock?

The Earnings per Share (EPS) of GH RESEARCH PLC (GHRS) is expected to decline by -12.22% in the next year.